Why Rural Healthcare Needs Smarter Tech and Better Policy
June 19th 2025In a conversation with Managed Healthcare Executive, 10XBeta CEO Marcel Botha suggested that in order to improve rural healthcare at a time when it’s threatened by potential Medicaid cuts, new technology must be designed with help from local communities. He added that federal policies should better support mobile care and telehealth services.
Watch
Communication, Team Stability Key To Improving Postpartum Hemorrhage Outcomes
June 19th 2025An experienced team of healthcare providers used to working together will likely be more successful when treating a postpartum hemorrhage, according to Abigail Wooldridge, assistant professor of Industrial and Enterprise Systems Engineering at The University of Illinois.
Watch
Rural Health Leaders Warn of Growing Gaps as Medicaid Cuts and Federal Shifts Loom
June 19th 2025Managed Healthcare Executive spoke with Ohio Rural Health Association leaders Rosanna Scott and Beth Kluding and Marcel Botha, CEO of healthcare technology company 10XBeta, to discuss how proposed Medicaid cuts and federal program changes could affect rural healthcare access, infrastructure and community well-being.
Watch
Nancy Hoyt Taff, M.P.H., Video Interview | 2025 MHE Emerging Leaders in Healthcare
June 18th 2025Nancy Hoyt Taff, M.P.H., is the senior product manager of Medicaid at UCare, an independent, nonprofit health plan providing healthcare and administrative services to more than 600,000 members throughout Minnesota and parts of western Wisconsin.
Watch
Jeffrey Casberg, M.S., of IPD Analytics and Luke Greenwalt, MBA, of IQVIA, both members of the Managed Healthcare Executive (MHE) editorial advisory board, will provide a midyear assessment of the pharmacy market and the policy and politics affecting it. Topics to be discussed include the possibility of tariffs, the most-favored nation drug pricing executive order, aspect of the reconciliation bill that could affect the pharmaceutical and pharmacy benefit management industries, pressure on the gross-to-net “bubble,” implementation of the Inflation Reduction Act price negotiations, GLP-1s and notable FDA approvals in the second half of 2025. Note that this a menu and some topics may be added or subtracted depending on time and news up to airtime on June 12. Peter Wehrwein, managing editor of MHE is moderating the discussion.
Watch
Postpartum Hemorrhage: Identifying Risks Saves Lives
June 11th 2025The United States has twice the postpartum hemorrhage mortality rate of other developed countries, which is why it’s essential to create and maintain safety protocols during obstetric emergencies, according to Abigail Wooldridge, assistant professor of Industrial and Enterprise Systems Engineering at The University of Illinois.
Watch
Cassie Houff, MBA, Video Interview | 2025 MHE Emerging Leaders in Healthcare
Published: June 6th 2025 | Updated: June 6th 2025Cassie Houff, MBA, says the most impactful change for U.S. healthcare would be “an overhaul to the fee-for-service payment system,” arguing that it doesn’t incentivize timely or necessary care.
Watch
Matthew Helbling, Pharm.D., Video Interview | 2025 MHE Emerging Leaders in Healthcare
June 6th 2025Matthew Helbling says the turning point in his pharmacy career came when he took on a pilot program for medication therapy management—and discovered the power of connecting more deeply with patients.
Watch
Cervical Cancer Screening Barriers Overcome With New Self-Testing Kit, Expert Says
June 5th 2025The Teal Wand was recently approved by the FDA as the first self-collection device to screen for cervical cancer, a major step forward for accessible women’s health, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
Watch
The New Healthcare Reality Under the Trump Administration
June 5th 2025In a panel moderated by Peter Wehrwein, managing editor of Managed Healthcare Executive three Washington, D.C., healthcare lobbyists with extensive D.C. experience discussed healthcare politics and policy dynamics under the Trump administration. Ryann Hill, M.P.H.; Patrick Cooney and Lindsay Greenleaf, J.D., MBA, said healthcare remains a top issue despite all the attention on immigration, tariffs and universities. Key issues include staffing cuts at HHS, with potential effects on the operations of the FDA and the Centers for Disease Control and Prevention. They also discussed the massive reconciliation bill and Medicaid changes, including work requirements and provider tax freezes, Medicare Advantage plan rate hikes and audits, and the May 12 drug pricing executive order and the implications of most-favored nation pricing.
Watch
Kathryn Boger, Ph.D., Video Interview | 2025 MHE Emerging Leaders in Healthcare
Published: June 5th 2025 | Updated: June 5th 2025Kathryn Boger, Ph.D., said leaving academic medicine to co-found InStride Health was both terrifying and transformative. Boger reflected on advice she received early and said, “If you’re feeling scared, it’s a sign that you’re growing.” This wisdom continues to shape her path today.
Watch
Pharmaceutical Tariffs Could Threaten Global Drug Supply Chains
June 4th 2025How pharmaceutical tariffs could reshape drug pricing, supply chains and domestic production in the United States, according to Eric Tichy, Pharm.D., M.B.A., vice chair of pharmacy formulary at the Mayo Clinic Health System.
Watch
Cervical Cancer: The Deadly, Preventable Disease
June 4th 2025Lack of insurance, financial instability and even fear are potential reasons women may forego their cervical cancer screening appointments, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
Watch
Satellos Bioscience's experimental small-molecule drug for Duchenne muscular dystrophy is showing positive results as a stand-alone treatment, but Phil Lambert, Ph.D., the company's chief scientific officer says the complexity of Duchenne muscular dystrophy may ultimately mean that a number of different therapies will be used together,
Watch
A Different Take on the Cause of Duchenne, and a Novel Small-Molecule Treatment to Match
June 3rd 2025Phil Lambert, Ph.D., chief scientific officer of Satellos Bioscience Inc., explains the mechanism of action of the company's experimental Duchenne muscular dystrophy drug, SAT-3247, and the thinking behind it.
Watch
CareOregon CEO Says Medicaid Work Rules Do More Harm Than Good
May 28th 2025In a conversation with Managed Healthcare Executive, Hunter expressed that work requirements are an effective way to manage Medicaid eligibility, but what is proposed will cause more harm to those who can't afford commercial healthcare.
Watch
Outpatient Pharmaceutical Spending to Outpace Hospital Pharmaceutical Spending in 2025
May 28th 2025A growing trend towards pharmaceutical outpatient treatment spending is driven by accessibility, according to Eric Tichy, Pharm.D., M.B.A., vice chair of pharmacy formulary at the Mayo Clinic Health System.
Watch